178 related articles for article (PubMed ID: 19005753)
1. Detection, purification and identification of an endogenous inhibitor of L-Dopa decarboxylase activity from human placenta.
Vassiliou AG; Fragoulis EG; Vassilacopoulou D
Neurochem Res; 2009 Jun; 34(6):1089-100. PubMed ID: 19005753
[TBL] [Abstract][Full Text] [Related]
2. Purification of an endogenous inhibitor of L-Dopa decarboxylase activity from human serum.
Vassiliou AG; Vassilacopoulou D; Fragoulis EG
Neurochem Res; 2005 May; 30(5):641-9. PubMed ID: 16176068
[TBL] [Abstract][Full Text] [Related]
3. Human L-Dopa decarboxylase interaction with annexin V and expression during apoptosis.
Chalatsa I; Arvanitis N; Arvanitis D; Tsakou AC; Kalantzis ED; Vassiliou AG; Sideris DC; Frakolaki E; Vassilaki N; Vassilacopoulou D
Biochimie; 2020 Oct; 177():78-86. PubMed ID: 32835737
[TBL] [Abstract][Full Text] [Related]
4. Use of radiolabeled monofluoromethyl-Dopa to define the subunit structure of human L-Dopa decarboxylase.
Maneckjee R; Baylin SB
Biochemistry; 1983 Dec; 22(26):6058-63. PubMed ID: 6661425
[TBL] [Abstract][Full Text] [Related]
5. L-DOPA decarboxylase association with membranes in mouse brain.
Poulikakos P; Vassilacopoulou D; Fragoulis EG
Neurochem Res; 2001 May; 26(5):479-85. PubMed ID: 11513473
[TBL] [Abstract][Full Text] [Related]
6. Presence of endogenous inhibitor of aromatic L-amino acid decarboxylase in monkey serum.
Rahman MK; Togari A; Kojima K; Takahashi K; Nagatsu T
Mol Cell Biochem; 1984 Aug; 63(1):53-8. PubMed ID: 6333583
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of human placental L-Dopa decarboxylase.
Siaterli MZ; Vassilacopoulou D; Fragoulis EG
Neurochem Res; 2003 Jun; 28(6):797-803. PubMed ID: 12718431
[TBL] [Abstract][Full Text] [Related]
8. L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin.
Vassiliou AG; Siaterli MZ; Frakolaki E; Gkogkosi P; Paspaltsis I; Sklaviadis T; Vassilacopoulou D; Vassilaki N
Biochimie; 2019 May; 160():76-87. PubMed ID: 30796964
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 5-methyl phenanthridium derivatives: a new class of human DOPA decarboxylase inhibitors.
Cheng P; Zhou J; Qing Z; Kang W; Liu S; Liu W; Xie H; Zeng J
Bioorg Med Chem Lett; 2014 Jun; 24(12):2712-6. PubMed ID: 24794108
[TBL] [Abstract][Full Text] [Related]
10. Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors.
Daidone F; Montioli R; Paiardini A; Cellini B; Macchiarulo A; Giardina G; Bossa F; Borri Voltattorni C
PLoS One; 2012; 7(2):e31610. PubMed ID: 22384042
[TBL] [Abstract][Full Text] [Related]
11. L-dopa decarboxylase in Ceratitis capitata white puparia and human: a comparative study.
Mappouras DG; Fragoulis EG
Comp Biochem Physiol B; 1990; 97(2):301-6. PubMed ID: 2253486
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterisation of L-DOPA decarboxylase from pharate pupae of Ceratitis capitata. A comparison with the enzyme purified from the white prepupae.
Bossinakou KS; Fragoulis EG
Comp Biochem Physiol B Biochem Mol Biol; 1996 Feb; 113(2):213-20. PubMed ID: 8653578
[TBL] [Abstract][Full Text] [Related]
13. A simplified method for purification of annexin V from human placenta.
Poghosyan GG; Melkonyan VZ; Mikaelyan MV; Gasparyan VK
Prep Biochem Biotechnol; 2003 Aug; 33(3):209-15. PubMed ID: 12916812
[TBL] [Abstract][Full Text] [Related]
14. Purification of annexin I and annexin II from human placental membranes by high-performance liquid chromatography.
Moore KG; Goulet F; Sartorelli AC
Protein Expr Purif; 1992 Feb; 3(1):1-7. PubMed ID: 1422205
[TBL] [Abstract][Full Text] [Related]
15. Rapid purification of annexin V from human placenta by affinity chromatography.
Mikaelyan MV; Poghosyan GG; Gasparyan VK
Prep Biochem Biotechnol; 2008; 38(2):152-7. PubMed ID: 18320466
[TBL] [Abstract][Full Text] [Related]
16. Annexin proteins PP4 and PP4-X. Comparative characterization of biological activities of placental and recombinant proteins.
Römisch J; Grote M; Weithmann KU; Heimburger N; Amann E
Biochem J; 1990 Nov; 272(1):223-9. PubMed ID: 2148260
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.
Rand JH; Wu XX; Guller S; Scher J; Andree HA; Lockwood CJ
Am J Obstet Gynecol; 1997 Oct; 177(4):918-23. PubMed ID: 9369845
[TBL] [Abstract][Full Text] [Related]
18. Purification of L-dopa decarboxylase from rat liver and production of polyclonal and monoclonal antibodies against it.
Ando-Yamamoto M; Hayashi H; Sugiyama T; Fukui H; Watanabe T; Wada H
J Biochem; 1987 Feb; 101(2):405-14. PubMed ID: 3584092
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's Disease: Recent Updates in the Identification of Human Dopa Decarboxylase Inhibitors.
Montioli R; Voltattorni CB; Bertoldi M
Curr Drug Metab; 2016; 17(5):513-8. PubMed ID: 27025882
[TBL] [Abstract][Full Text] [Related]
20. Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label.
Bertoldi M; Dominici P; Moore PS; Maras B; Voltattorni CB
Biochemistry; 1998 May; 37(18):6552-61. PubMed ID: 9572873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
